Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Debt Ratio (2021 - 2024)

Standard Biotools (LAB) has disclosed Debt Ratio for 7 consecutive years, with 0.08 as the latest value for Q3 2024.

  • On a quarterly basis, Debt Ratio rose 184.32% to 0.08 in Q3 2024 year-over-year; TTM through Sep 2024 was 0.08, a 184.32% increase, with the full-year FY2023 number at 0.18, up 754.34% from a year prior.
  • Debt Ratio was 0.08 for Q3 2024 at Standard Biotools, up from 0.07 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.18 in Q4 2023 to a low of 0.02 in Q4 2022.
  • A 4-year average of 0.05 and a median of 0.03 in 2021 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: plummeted 42.5% in 2022, then surged 754.34% in 2023.
  • Standard Biotools' Debt Ratio stood at 0.04 in 2021, then tumbled by 42.5% to 0.02 in 2022, then soared by 754.34% to 0.18 in 2023, then crashed by 55.08% to 0.08 in 2024.
  • Per Business Quant, the three most recent readings for LAB's Debt Ratio are 0.08 (Q3 2024), 0.07 (Q1 2024), and 0.18 (Q4 2023).